Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Industry News
AMRI Renews NIH Contract
Re-ups 10-year NIH contract to support the Blueprint Neurotherapeutics Network04.20.18
-
Bio News | Collaborations & Alliances | Industry News
ProBioGen, Tizona Therapeutics Enter Collaboration
To develop immune system centered treatments for cancer04.18.18
-
Breaking News | Collaborations & Alliances | Industry News
SAMDI Tech Enters Drug Discovery Collaboration
Forms partnership with Enamine to expand small molecule compound libraries04.17.18
-
Bio News | Collaborations & Alliances | Industry News
Telix, INSERM, and ARRONAX Enter Agreement
To explore the feasibility of using several of Telix's clinical targeting agents with astatine04.16.18
-
Bio News | Collaborations & Alliances | Industry News
Idera, Pillar Partners Enter Agreement
Pillar Partners will provide funding to support three clinical trials to expand the clinical research of Idera's IMO-212504.16.18
-
Bio News | Collaborations & Alliances | Industry News
Kineta, Genentech Enter Collaboration
To develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain04.16.18
-
Bio News | Collaborations & Alliances | Facilities | Industry News
Sartorius Stedim Biotech, Penn State Enter Partnership
To support the education and preparation of the next generation of biotechnology leaders04.16.18
-
Bio News | Collaborations & Alliances | Industry News | Trials & Filings
-
Industry News | Promotions & Moves
Selexis Installs $2M in New Lab Equipment
The company also made key strategic hires and signed its one hundredth commercial license agreement (CLA)04.12.18
-
Bio News | Collaborations & Alliances | Industry News
GSK, Orchard Therapeutics Enter Strategic Agreement
GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard04.12.18
-
Bio News | Breaking News | Industry News | Regulatory Affairs
Emergent Completes Market Authorization
For BioThrax (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU)04.12.18
-
Bio News | Collaborations & Alliances | Facilities | Industry News
MilliporeSigma, Oxford University Enter Partnership
To develop a vaccine manufacturing facility in Ghana and to expand their scalable vaccine manufacturing processes04.12.18
-
Bio News | Breaking News | Industry News | Trials & Filings
FDA Approves Novartis’ Afinitor
For the treatment of adult and pediatric patients with tuberous sclerosis complex with associated partial onset seizures04.11.18
-
Bio News | Collaborations & Alliances | Industry News
Zealand, Roche Diabetes Care Enter Collaboration
For the Phase 3 trials with dasiglucagon for treatment of congenital hyperinsulinism (CHI)04.11.18
-
Bio News | Collaborations & Alliances | Industry News
Inovio, CEPI Enter Partnership
Inovio will develop vaccine candidates against Lassa fever and Middle East Respiratory Syndrome04.11.18
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Novartis Inks $8.7B Deal to Acquire AveXis
Novartis will pay $218 a share of AveXis in cash, an 88% premium to its closing price on April 604.10.18
-
Preclinical Partnerships
Bill Barbo of Charles River discusses drug discovery and outsourcing trends in today’s marketOnline Exclusives04.10.18
-
Bio News | Collaborations & Alliances | Industry News
Wave Life Sciences, Deep Genomics Enter Collaboration
To identify novel therapies to be developed by Wave for the treatment of genetic neuromuscular disorders.04.10.18
-
Breaking News | Collaborations & Alliances | Industry News
Promethera Biosciences Acquires Baliopharm
Promethera will now have control over Baliopharm’s entire antibody development programs04.10.18
-
CRO News
Charles River, PathoQuest Expand Strategic Biologics Pact
Charles River will provide clients access to PathoQuest’s NGS-based testing solutions04.09.18
